| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Crew Timothy C |
Chief Executive Officer |
• – – |
2019-08-29 |
4 |
AB |
$8.45 |
$16,900 |
D/D |
2,000 |
183,884 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$9,297 |
D/D |
(1,332) |
97,142 |
|
- |
|
| Kozlowski John |
Chief of Staff & Strategy |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$5,752 |
D/D |
(824) |
51,492 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$3,706 |
D/D |
(531) |
45,805 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$3,902 |
D/D |
(559) |
46,912 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$4,014 |
D/D |
(575) |
39,471 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-07-30 |
4 |
D |
$6.98 |
$8,006 |
D/D |
(1,147) |
68,283 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
47,680 |
98,474 |
|
- |
|
| Kozlowski John |
Chief of Staff & Strategy |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
28,650 |
52,316 |
|
- |
|
| Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
42,720 |
63,973 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
25,250 |
46,336 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,080 |
47,471 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
40,046 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
40,210 |
69,430 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
129,590 |
181,884 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-07-27 |
4 |
D |
$6.55 |
$773 |
D/D |
(118) |
27,546 |
|
- |
|
| Kozlowski John |
Chief of Staff & Strategy |
• – – |
2019-07-27 |
4 |
D |
$6.55 |
$799 |
D/D |
(122) |
23,666 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-07-27 |
4 |
D |
$6.55 |
$694 |
D/D |
(106) |
21,086 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-07-27 |
4 |
D |
$6.55 |
$727 |
D/D |
(111) |
31,391 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2019-07-27 |
4 |
D |
$6.55 |
$1,094 |
D/D |
(167) |
50,794 |
|
- |
|
| Chapman John C |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
46,019 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
176,340 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
73,722 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
81,415 |
|
- |
|
| Farber Jeffrey |
Director |
– • – |
2019-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
33,445 |
2,134,499 |
|
- |
|
762 Records found
|
|
Page 7 of 31 |
|
|
